Skip to main content
Top
Published in: Drugs & Aging 4/2016

01-04-2016 | Review Article

Reducing Polypharmacy from the Perspectives of General Practitioners and Older Patients: A Synthesis of Qualitative Studies

Authors: Beate Bokhof, Ulrike Junius-Walker

Published in: Drugs & Aging | Issue 4/2016

Login to get access

Abstract

Background

Polypharmacy, common in elderly multimorbid adults, leads to increased iatrogenic health risks. Yet, no consistent approach to stopping medicines exists in primary healthcare.

Objectives

Our objective was to synthesize qualitative studies exploring the perspectives and experiences of general practitioners (GPs) and older patients in reducing polypharmacy and to discover approaches already being practiced.

Methods

We conducted a search in the PubMed, Cochrane Library, Web of Science Core Collection, and Scopus databases to identify qualitative studies in the primary care setting addressing multimorbid older patients and polypharmacy reduction. The seven-step model of meta-ethnography allowed for cross-interpretation between studies considering their original context and developing theories.

Results

A total of 14 studies from the perspectives of patients (n = 6) and providers (n = 8) were included, although discontinuing medicines only occurred as a sub-theme in patient studies. Emerging key concepts for patients were experimenting with medicines, attitudes and experiences towards medicines, necessity of prioritizing treatments, relationship to GP, and system-related contributors. For GPs, they covered assumptions about elderly patients, interface prescribing problems, evidence-based guidelines, failure to meet the challenge of complex decision-making, and solutions.

Discussion

Complex medication regimens and uncertainties in decision making are challenges for both GPs and patients. For patients, symptom experiences with medicines, relationship with their prescriber, and fragmented care are at the forefront; for GPs, it is the decision-making responsibility in the context of unsuitable guidelines, time constraints, and deficient multidisciplinary co-operation. Heuristics such as prioritizing and individualizing treatments and relaxation of guidelines emerged. These strategies require professional awareness of the problem and establishing a trusting, patient-centered consultation style and supportive work conditions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Haefeli WE. Polypharmazie. Swiss Med Forum. 2011;47:847–52. Haefeli WE. Polypharmazie. Swiss Med Forum. 2011;47:847–52.
3.
go back to reference Viniol A, Bösner S, Baum E, et al. Forgotten drugs: long-term prescriptions of thyroid hormones – a cross sectional study. Int J Gen Med. 2013;6:329–34.CrossRefPubMedPubMedCentral Viniol A, Bösner S, Baum E, et al. Forgotten drugs: long-term prescriptions of thyroid hormones – a cross sectional study. Int J Gen Med. 2013;6:329–34.CrossRefPubMedPubMedCentral
4.
go back to reference Keller H, Hirsch O, Kaufmann-Kolle P, et al. Evaluating an implementation strategy in cardiovascular prevention to improve prescribing of statins in Germany: an intention to treat analysis. BMC Public Health. 2013;13:623.CrossRefPubMedPubMedCentral Keller H, Hirsch O, Kaufmann-Kolle P, et al. Evaluating an implementation strategy in cardiovascular prevention to improve prescribing of statins in Germany: an intention to treat analysis. BMC Public Health. 2013;13:623.CrossRefPubMedPubMedCentral
5.
go back to reference Deveugele M, Derese A, van den Brink-Muinen A, et al. Consulting length in general practice: cross sectional study in six European countries. BMJ. 2002;325:472.CrossRefPubMedPubMedCentral Deveugele M, Derese A, van den Brink-Muinen A, et al. Consulting length in general practice: cross sectional study in six European countries. BMJ. 2002;325:472.CrossRefPubMedPubMedCentral
6.
go back to reference Burkhardt H, Wehling M. Probleme bei der Pharmakotherapie älterer Menschen. Der Internist. 2010;51:737–48.CrossRefPubMed Burkhardt H, Wehling M. Probleme bei der Pharmakotherapie älterer Menschen. Der Internist. 2010;51:737–48.CrossRefPubMed
8.
go back to reference Gnjidic D, Le Couteur DG, Kouladjian L, et al. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med. 2012;28:237–53.CrossRefPubMed Gnjidic D, Le Couteur DG, Kouladjian L, et al. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med. 2012;28:237–53.CrossRefPubMed
9.
go back to reference Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:345–51.CrossRefPubMed Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:345–51.CrossRefPubMed
10.
go back to reference Rottenkolber D, Schmiedl S, Rottenkolber M, et al. Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations. Pharmacoepidemiol Drug Saf. 2011;20:626–34.CrossRefPubMed Rottenkolber D, Schmiedl S, Rottenkolber M, et al. Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations. Pharmacoepidemiol Drug Saf. 2011;20:626–34.CrossRefPubMed
11.
go back to reference Steinman MA, Landefeld CS, Rosenthal GE, et al. Polypharmacy and prescribing quality in older people. JAGS. 2006;54:1516–23.CrossRef Steinman MA, Landefeld CS, Rosenthal GE, et al. Polypharmacy and prescribing quality in older people. JAGS. 2006;54:1516–23.CrossRef
12.
go back to reference Junius-Walker U, Theile G, Hummers-Pradier E. Prevalence and predictors of polypharmacy among older primary care patients in Germany. Fam Pract. 2007;24:14–9.CrossRefPubMed Junius-Walker U, Theile G, Hummers-Pradier E. Prevalence and predictors of polypharmacy among older primary care patients in Germany. Fam Pract. 2007;24:14–9.CrossRefPubMed
13.
go back to reference Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs. 2005;31:4–11.CrossRefPubMed Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs. 2005;31:4–11.CrossRefPubMed
14.
go back to reference Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365:2002–12.CrossRefPubMed Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365:2002–12.CrossRefPubMed
16.
go back to reference de Vries ThP, Henning RH, Hogerzeil HV, et al. Guide to good prescribing. Geneva: World Health Organization; 1995. de Vries ThP, Henning RH, Hogerzeil HV, et al. Guide to good prescribing. Geneva: World Health Organization; 1995.
17.
go back to reference Woodward MC. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res. 2003;33:323–8.CrossRef Woodward MC. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res. 2003;33:323–8.CrossRef
18.
go back to reference Scott IA, Gray LD, Martin JH, et al. Deciding when to stop: towards evidence-based deprescribing of drugs in older populations. Evid Based Med. 2013;18:121–4.CrossRefPubMed Scott IA, Gray LD, Martin JH, et al. Deciding when to stop: towards evidence-based deprescribing of drugs in older populations. Evid Based Med. 2013;18:121–4.CrossRefPubMed
19.
go back to reference Scott IA, Gray LD, Martin JH, et al. Minimizing inappropriate medications in older populations: a 10-step conceptual framework. Am J Med. 2012;125:529–37.CrossRefPubMed Scott IA, Gray LD, Martin JH, et al. Minimizing inappropriate medications in older populations: a 10-step conceptual framework. Am J Med. 2012;125:529–37.CrossRefPubMed
20.
go back to reference Scott IA, Anderson K, Freeman CR, et al. First do no harm: a real need to describe in older patients. Med J Aust. 2014;201:390–2.CrossRefPubMed Scott IA, Anderson K, Freeman CR, et al. First do no harm: a real need to describe in older patients. Med J Aust. 2014;201:390–2.CrossRefPubMed
21.
go back to reference Scott IA, Le Couteur DG. Physicians need to take the lead in deprescribing. Int Med J. 2015;45:352–6.CrossRef Scott IA, Le Couteur DG. Physicians need to take the lead in deprescribing. Int Med J. 2015;45:352–6.CrossRef
22.
go back to reference Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy. The process of deprescribing. JAMA. Intern Med. 2015;175:827–34. Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy. The process of deprescribing. JAMA. Intern Med. 2015;175:827–34.
23.
go back to reference Campanelli CM. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults: The American Geriatrics Society 2015 Beers Criteria Update Expert Panel. J Am Geriatr Soc. 2012;60:616–31.CrossRefPubMedCentral Campanelli CM. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults: The American Geriatrics Society 2015 Beers Criteria Update Expert Panel. J Am Geriatr Soc. 2012;60:616–31.CrossRefPubMedCentral
24.
go back to reference Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107:543–51.PubMedPubMedCentral Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107:543–51.PubMedPubMedCentral
25.
go back to reference O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–8.CrossRefPubMedPubMedCentral O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–8.CrossRefPubMedPubMedCentral
26.
go back to reference Wehling M. Drug therapy in the elderly: too much or too little, what to do? A new assessment system: fit for the aged (FORTA). Dtsch Med Wochenschr. 2008;133:2289–91.CrossRefPubMed Wehling M. Drug therapy in the elderly: too much or too little, what to do? A new assessment system: fit for the aged (FORTA). Dtsch Med Wochenschr. 2008;133:2289–91.CrossRefPubMed
28.
go back to reference Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults. Arch Intern Med. 2010;170:1648–54.CrossRefPubMed Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults. Arch Intern Med. 2010;170:1648–54.CrossRefPubMed
29.
go back to reference Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45:1045–51.CrossRefPubMed Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45:1045–51.CrossRefPubMed
31.
go back to reference Noblit GW, Hare RD. Meta-ethnography: synthesizing qualitative studies. Newbury Park: Sage; 1988. Noblit GW, Hare RD. Meta-ethnography: synthesizing qualitative studies. Newbury Park: Sage; 1988.
32.
go back to reference Britten N, Campbell R, Pope C, et al. Using meta-ethnography to synthesise qualitative research: a worked example. J Health Serv Res Policy. 2002;7:209–15.CrossRefPubMed Britten N, Campbell R, Pope C, et al. Using meta-ethnography to synthesise qualitative research: a worked example. J Health Serv Res Policy. 2002;7:209–15.CrossRefPubMed
33.
go back to reference Campbell R, Pound P, Morgan M, et al. Evaluating meta-ethnography: systematic analysis and synthesis of qualitative research. Health Technol Assess. 2011;15:1–164.CrossRefPubMed Campbell R, Pound P, Morgan M, et al. Evaluating meta-ethnography: systematic analysis and synthesis of qualitative research. Health Technol Assess. 2011;15:1–164.CrossRefPubMed
34.
go back to reference Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;9:349–57.CrossRef Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;9:349–57.CrossRef
35.
go back to reference Campbell R, Pound P, Pope C, et al. Evaluating meta-ethnography: a synthesis of qualitative research on lay experiences of diabetes and diabetes care. Soc Sci Med. 2003;56:671–84.CrossRefPubMed Campbell R, Pound P, Pope C, et al. Evaluating meta-ethnography: a synthesis of qualitative research on lay experiences of diabetes and diabetes care. Soc Sci Med. 2003;56:671–84.CrossRefPubMed
36.
go back to reference Tordoff J, Simonsen K, Thomson WM, et al. „It’s just routine”. A qualitative study of medicine taking amongst older adults in New Zealand. Pharm World Sci. 2010;32:154–61.CrossRefPubMed Tordoff J, Simonsen K, Thomson WM, et al. „It’s just routine”. A qualitative study of medicine taking amongst older adults in New Zealand. Pharm World Sci. 2010;32:154–61.CrossRefPubMed
37.
go back to reference Torrible SJ, Hogan DB. Medication use and rural seniors. Who really knows what they are taking? Can Fam Physician. 1997;43:893–8.PubMedPubMedCentral Torrible SJ, Hogan DB. Medication use and rural seniors. Who really knows what they are taking? Can Fam Physician. 1997;43:893–8.PubMedPubMedCentral
38.
go back to reference Gröber-Grätz D, Waldmann UM, Metzinger U, et al. Reasons of changes in drug therapy after hospital discharge: a qualitative study of perception by general practitioners and patients. Gesundheitswesen. 2014;76:639–44.CrossRefPubMed Gröber-Grätz D, Waldmann UM, Metzinger U, et al. Reasons of changes in drug therapy after hospital discharge: a qualitative study of perception by general practitioners and patients. Gesundheitswesen. 2014;76:639–44.CrossRefPubMed
39.
go back to reference Krska J, Morecroft CW, Poole H, et al. Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study. Int J Clin Pharm. 2013;35:1161–9.CrossRefPubMed Krska J, Morecroft CW, Poole H, et al. Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study. Int J Clin Pharm. 2013;35:1161–9.CrossRefPubMed
40.
go back to reference Linsky A, Simon SR, Bokhour B. Patient perceptions of proactive medication discontinuation. Patient Educ Couns. 2015;98:220–5.CrossRefPubMed Linsky A, Simon SR, Bokhour B. Patient perceptions of proactive medication discontinuation. Patient Educ Couns. 2015;98:220–5.CrossRefPubMed
41.
go back to reference Post SG, Stuckey JC, Whitehouse PJ, et al. A focus group on cognition-enhancing medications in Alzheimer disease: disparities between professionals and consumers. Alzheimer Dis Assoc Disord. 2001;15:80–8.CrossRefPubMed Post SG, Stuckey JC, Whitehouse PJ, et al. A focus group on cognition-enhancing medications in Alzheimer disease: disparities between professionals and consumers. Alzheimer Dis Assoc Disord. 2001;15:80–8.CrossRefPubMed
42.
go back to reference Unson CG, Siccion E, Gaztambide J, et al. Nonadherence and osteoporosis treatment preferences of older women: a qualitative study. J Womens Health (Larchmt). 2003;12:1037–45.CrossRef Unson CG, Siccion E, Gaztambide J, et al. Nonadherence and osteoporosis treatment preferences of older women: a qualitative study. J Womens Health (Larchmt). 2003;12:1037–45.CrossRef
43.
go back to reference Givens JL, Datto CJ, Ruckdeschel K, et al. Older patients’ aversion to antidepressants: a qualitative study. J Gen Intern Med. 2006;21:146–51.PubMedPubMedCentral Givens JL, Datto CJ, Ruckdeschel K, et al. Older patients’ aversion to antidepressants: a qualitative study. J Gen Intern Med. 2006;21:146–51.PubMedPubMedCentral
45.
go back to reference Spinewine A, Swine C, Dhillon S, et al. Appropriateness of use of medicines in elderly inpatients: qualitative study. BMJ. 2005;3331:935.CrossRef Spinewine A, Swine C, Dhillon S, et al. Appropriateness of use of medicines in elderly inpatients: qualitative study. BMJ. 2005;3331:935.CrossRef
46.
go back to reference Yegenoglu S, Baydar T. Information and observation of community pharmacists on geriatric patients: a qualitative study in Ankara City. Turk J Geriatr. 2011;14:344–51. Yegenoglu S, Baydar T. Information and observation of community pharmacists on geriatric patients: a qualitative study in Ankara City. Turk J Geriatr. 2011;14:344–51.
47.
go back to reference Farrell B, Tsang C, Raman-Wilms L, et al. What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified Delphi process. PLoS One. 2015;10:e0122246.CrossRefPubMedPubMedCentral Farrell B, Tsang C, Raman-Wilms L, et al. What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified Delphi process. PLoS One. 2015;10:e0122246.CrossRefPubMedPubMedCentral
48.
go back to reference Schuling J, Gebben H, Veehof LJ, et al. Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study. BMC Fam Pract. 2012;13:56.CrossRefPubMed Schuling J, Gebben H, Veehof LJ, et al. Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study. BMC Fam Pract. 2012;13:56.CrossRefPubMed
49.
go back to reference Herrmann ML, von Waldegg GH, Kip M, et al. GP Medication prioritisation in older patients with multiple comorbidities recently discharged from hospital: a case-based bottom-up approach. Gesundheitswesen. 2015;77:16–23.PubMed Herrmann ML, von Waldegg GH, Kip M, et al. GP Medication prioritisation in older patients with multiple comorbidities recently discharged from hospital: a case-based bottom-up approach. Gesundheitswesen. 2015;77:16–23.PubMed
50.
go back to reference Elliott RA, Ross-Degnan D, Adams AS, et al. Strategies for coping in a complex world: adherence behavior among older adults with chronic illness. J Gen Intern Med. 2007;22:805–10.CrossRefPubMedPubMedCentral Elliott RA, Ross-Degnan D, Adams AS, et al. Strategies for coping in a complex world: adherence behavior among older adults with chronic illness. J Gen Intern Med. 2007;22:805–10.CrossRefPubMedPubMedCentral
51.
go back to reference Bagge M, Tordoff J, Norris P, et al. Older people’s attitudes towards their regular medicines. J Prim Health Care. 2013;5:234–42.PubMed Bagge M, Tordoff J, Norris P, et al. Older people’s attitudes towards their regular medicines. J Prim Health Care. 2013;5:234–42.PubMed
52.
go back to reference Meranius MS, Hammar LM. How does the healthcare system affect medication self-management among older adults with multimorbidity? Scand J Caring Sci. 2015. doi:10.1111/scs.12225.PubMed Meranius MS, Hammar LM. How does the healthcare system affect medication self-management among older adults with multimorbidity? Scand J Caring Sci. 2015. doi:10.​1111/​scs.​12225.PubMed
53.
go back to reference Moen J, Bohma A, Tillenius T, et al. ‘‘I don’t know how many of these [medicines] are necessary’: a focus group study among elderly users of multiple medicines. Patient Educ Couns. 2009;74:135–41.CrossRefPubMed Moen J, Bohma A, Tillenius T, et al. ‘‘I don’t know how many of these [medicines] are necessary’: a focus group study among elderly users of multiple medicines. Patient Educ Couns. 2009;74:135–41.CrossRefPubMed
54.
go back to reference Marx G, Püsche K, Ahrens D, et al. Polypharmacy: a dilemma in primary care? Results of group discussions with general practitioners. Gesundheitswesen. 2009;71:339–48.CrossRefPubMed Marx G, Püsche K, Ahrens D, et al. Polypharmacy: a dilemma in primary care? Results of group discussions with general practitioners. Gesundheitswesen. 2009;71:339–48.CrossRefPubMed
55.
go back to reference Moen J, Norrgård S, Antonov K, et al. GPs’ perceptions of multiple-medicine use in older patients. J Eval Clin Pract. 2010;16:69–75.CrossRefPubMed Moen J, Norrgård S, Antonov K, et al. GPs’ perceptions of multiple-medicine use in older patients. J Eval Clin Pract. 2010;16:69–75.CrossRefPubMed
56.
57.
go back to reference Sinnott C, McHugh SM, Boyce MB, et al. What to give the patient who has everything? A qualitative study of prescribing for multimorbidity in primary care. Br J Gen Pract. 2015;65:e184–91.CrossRefPubMedPubMedCentral Sinnott C, McHugh SM, Boyce MB, et al. What to give the patient who has everything? A qualitative study of prescribing for multimorbidity in primary care. Br J Gen Pract. 2015;65:e184–91.CrossRefPubMedPubMedCentral
58.
go back to reference Smith SM, O’Kelly S, O’Dowd T. GPs’ and pharmacists’ experiences of managing multimorbidity: a ‘Pandora’s box’. Br J Gen Pract. 2010;60:285–94.CrossRefPubMed Smith SM, O’Kelly S, O’Dowd T. GPs’ and pharmacists’ experiences of managing multimorbidity: a ‘Pandora’s box’. Br J Gen Pract. 2010;60:285–94.CrossRefPubMed
59.
go back to reference Fried TR, McGraw S, Agostini JV, et al. Views of older persons with multiple morbidities on competing outcomes and clinical decision-making. J Am Geriatr Soc. 2008;56:1839–44.CrossRefPubMedPubMedCentral Fried TR, McGraw S, Agostini JV, et al. Views of older persons with multiple morbidities on competing outcomes and clinical decision-making. J Am Geriatr Soc. 2008;56:1839–44.CrossRefPubMedPubMedCentral
60.
go back to reference Berne E. Principles of transactional analysis. Indian J Psychiat. 1996;38:154–9. Berne E. Principles of transactional analysis. Indian J Psychiat. 1996;38:154–9.
61.
go back to reference Anderson K, Stowasser D, Freeman C, et al. Prescriber barriers and enablers to minimizing potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014;4:e006544.CrossRefPubMedPubMedCentral Anderson K, Stowasser D, Freeman C, et al. Prescriber barriers and enablers to minimizing potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014;4:e006544.CrossRefPubMedPubMedCentral
62.
go back to reference Cullinan S, O’Mahony D, Fleming A, et al. A meta-synthesis of potentially inappropriate prescribing in older patients. Drugs Aging. 2014;31:631–8.CrossRefPubMed Cullinan S, O’Mahony D, Fleming A, et al. A meta-synthesis of potentially inappropriate prescribing in older patients. Drugs Aging. 2014;31:631–8.CrossRefPubMed
63.
go back to reference Sinnott C, McHugh S, Browne J, et al. GPs’ perspectives on the management of patients with multimorbidity: systematic review and synthesis of qualitative research. BMJ Open. 2013;3:e003610.CrossRefPubMedPubMedCentral Sinnott C, McHugh S, Browne J, et al. GPs’ perspectives on the management of patients with multimorbidity: systematic review and synthesis of qualitative research. BMJ Open. 2013;3:e003610.CrossRefPubMedPubMedCentral
64.
go back to reference Reeve E, To J, Hendrix I, et al. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013;30:793–807.CrossRefPubMed Reeve E, To J, Hendrix I, et al. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013;30:793–807.CrossRefPubMed
65.
go back to reference Reeve E, Shakib S, Hendrix I, et al. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br J Clin Pharmacol. 2014;78:738–47.CrossRefPubMedPubMedCentral Reeve E, Shakib S, Hendrix I, et al. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br J Clin Pharmacol. 2014;78:738–47.CrossRefPubMedPubMedCentral
66.
go back to reference Neuner-Jehle S, Krones T, Senn O. Systematic deprescribing of medicaments is accepted and feasible among polymorbid family medicine patients. Praxis. 2014;103:317–22.CrossRefPubMed Neuner-Jehle S, Krones T, Senn O. Systematic deprescribing of medicaments is accepted and feasible among polymorbid family medicine patients. Praxis. 2014;103:317–22.CrossRefPubMed
67.
go back to reference Cooper JA, Cadogan CA, Patterson SM, et al. Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review. BMJ Open. 2015;5:e009235.CrossRefPubMedPubMedCentral Cooper JA, Cadogan CA, Patterson SM, et al. Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review. BMJ Open. 2015;5:e009235.CrossRefPubMedPubMedCentral
68.
go back to reference Scottish Government Model of Care Polypharmacy Working Group. Polypharmacy Guidance. 2nd ed. Scottish Government; 2015. Scottish Government Model of Care Polypharmacy Working Group. Polypharmacy Guidance. 2nd ed. Scottish Government; 2015.
Metadata
Title
Reducing Polypharmacy from the Perspectives of General Practitioners and Older Patients: A Synthesis of Qualitative Studies
Authors
Beate Bokhof
Ulrike Junius-Walker
Publication date
01-04-2016
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 4/2016
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-016-0354-5

Other articles of this Issue 4/2016

Drugs & Aging 4/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.